Healthcare -
Biotechnology - NASDAQ - US
$ 18.415
2.93 %
$ 1.27 B
Market Cap
-3.84
P/E
ARVN - REVENUE
Revenue ARVN - Arvinas, Inc.
78.5 M
LAST VALUE
29.65%
2 YEAR CAGR
40.53%
5 YEAR CAGR
0.00%
10 YEAR CAGR